U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H16ClNO4
Molecular Weight 357.788
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-803467

SMILES

COC1=CC(OC)=CC(NC(=O)C2=CC=C(O2)C3=CC=C(Cl)C=C3)=C1

InChI

InChIKey=VHKBTPQDHDSBSP-UHFFFAOYSA-N
InChI=1S/C19H16ClNO4/c1-23-15-9-14(10-16(11-15)24-2)21-19(22)18-8-7-17(25-18)12-3-5-13(20)6-4-12/h3-11H,1-2H3,(H,21,22)

HIDE SMILES / InChI
A-803467 is a selective NaV1.8 channel blocker with IC50 of 8 nM, blocks tetrodotoxin-resistant currents, exhibits >100-fold selectivity against human NaV1.2, NaV1.3, NaV1.5, and NaV1.7. A-803467 reduces behavioral measures of chronic pain. Systemic administration of A-803467 demonstrated acute antinociceptive activity as measured as a reduction in mechanical allodynia in several models of inflammatory and neuropathic pain in rats. Additionally, systemic and intraspinal delivery of A-803467 attenuates both evoked and spontaneous firing of wide dynamic range neurons in rats with spinal nerve ligations.

CNS Activity

Curator's Comment: A-803467, which shows good penetration into the central nervous system, produced more robust antinociception in neuropathic pain models than a peripherally acting nonselective sodium channel blocker.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
8.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: A-803467 also dose-dependently reduced mechanical allodynia in a variety of rat pain models including: spinal nerve ligation (ED(50) = 47 mg/kg, i.p.), sciatic nerve injury (ED(50) = 85 mg/kg, i.p.), capsaicin-induced secondary mechanical allodynia (ED(50) approximately 100 mg/kg, i.p.), and thermal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50) = 41 mg/kg, i.p.).
Rats: systemic administration of A-803467 (20 mg/kg, i.v.) to spinal nerve ligated rats, significantly reduced both spontaneous and von Frey hairevoked firing of spinal dorsal horn wide dynamic range neurons by 66% and 53%, respectively compared with baseline levels.
Route of Administration: Intravenous
A-803467 potently blocks recombinant human or rat NaV1.8 channels with IC50 of 8 nM and 45 nM, respectively, at a holding potential of -40 mV. At a resting state, A-803467 also potently blocks human NaV1.8 channels with IC50 of 79 nM. A-803467 blocks tetrodotoxin-resistant (TTX-R) currents in rat dorsal root ganglion neurons in a concentration-dependent manner with IC50 of 140 nM. A-803467 at 0.3 uM but not 0.1 uM significantly inhibits the generation of spontaneous and electrically evoked action potentials.
Name Type Language
A-803467
Common Name English
2-FURANCARBOXAMIDE, 5-(4-CHLOROPHENYL)-N-(3,5-DIMETHOXYPHENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
339LBH1395
Created by admin on Sat Dec 16 10:04:13 GMT 2023 , Edited by admin on Sat Dec 16 10:04:13 GMT 2023
PRIMARY
EPA CompTox
DTXSID90241480
Created by admin on Sat Dec 16 10:04:13 GMT 2023 , Edited by admin on Sat Dec 16 10:04:13 GMT 2023
PRIMARY
PUBCHEM
16038374
Created by admin on Sat Dec 16 10:04:13 GMT 2023 , Edited by admin on Sat Dec 16 10:04:13 GMT 2023
PRIMARY
CAS
944261-79-4
Created by admin on Sat Dec 16 10:04:13 GMT 2023 , Edited by admin on Sat Dec 16 10:04:13 GMT 2023
PRIMARY